A new version of the controversial bill removes the specific company names that were included in a previous iteration but still requires the industry to ditch Chinese biotech contractors in order to r...

A blog about Groovy, Java, Clojure, Asciidoctor, Gradle and other cool developer subjects.

A blog about Groovy, Java, Clojure, Asciidoctor, Gradle and other cool developer subjects.

Millions of Americans depend on Obamacare. Here's where they live.

Visitors to Athens can now enjoy an unobstructed view of the Parthenon. The scaffolding on the western façade, set up for conservation work 20 years ago, has been removed.

Samsara BioCapital seeks to raise $200M for opportunity fund, having secured $98M from 19 investors. Firm has made 180+ investments since 2017, including Abcuro and Dewpoint.

The 2025 Trailblazers guest editor uses computational models to study lung chemistry while building resources that help blind scientists succeed

Scientists are beginning to understand the sudden loss of sea ice in Antarctica – and there is growing evidence that it represents a permanent shift with potentially catastrophic consequences

Endurance, the wooden ship that Ernest Shackleton took to Antarctica in 1915, wasn't built to withstand frozen seas – and the famous explorer knew it

CDC staff behind the agency’s flagship publication have been fired amid drastic cuts to the HHS promised by the White House due to the government shutdown, according to five people familiar with the s...

The Danish pharma will acquire Akero Therapeutics

In what reads like science fiction, researchers have successfully weaponized bacteria to infiltrate tumors and deliver immune-boosting genetic payloads directly to cancer cells. The experimental therapy, called ACTM-838, shrank tumors in mice and prevented them from returning, even when scientists tried to re-infect cured animals with fresh cancer cells. The approach exploits a peculiar biological quirk: certain bacteria naturally gravitate toward tumors like moths to a flame.

In what experts are calling a paradigm-shifting landmark study, scientists from the OSUCCC – James report key findings about the underlying mechanisms of

Transparency is a word pharma companies often like to use, but, in practice, they rarely live up to the ideal. | Transparency is often a word pharma companies like to use, but in practice, they rarely...

Glioblastoma is less aggressive after treatment with resveratrol and copper, study indicates. The potentially game-changing finding sows the seeds of a radically different approach to the treatment of...

Women living close to federally designated Superfund sites are more likely to develop aggressive breast cancers — including the hard-to-treat triple-negative subtype — according to new stu...

Researchers at Cleveland Clinic Children’s have helped identify a previously unknown gene that increases the risk of developing osteosarcoma, the most common type of malignant bone tumor in chil...

Bristol Myers Squibb acquires Orbital Therapeutics for $1.5B cash to expand in vivo CAR-T therapy development, focusing on autoimmune diseases with OTX-201 program.